Literature DB >> 18384890

How and why do GPCRs dimerize?

Vsevolod V Gurevich1, Eugenia V Gurevich.   

Abstract

Dimerization is fairly common in the G-protein-coupled receptor (GPCR) superfamily. First attempts to rationalize this phenomenon gave rise to an idea that two receptors in a dimer could be necessary to bind a single molecule of G protein or arrestin. Although GPCRs, G proteins and arrestins were crystallized only in their inactive conformations (in which they do not interact), the structures appeared temptingly compatible with this beautiful model. However, it did not survive the rigors of experimental testing: several recent studies unambiguously demonstrated that one receptor molecule is sufficient to activate a G protein and bind arrestin. Thus, to figure out the biological role of receptor self-association we must focus on other functions of GPCRs at different stages of their functional cycle.

Mesh:

Substances:

Year:  2008        PMID: 18384890      PMCID: PMC2652501          DOI: 10.1016/j.tips.2008.02.004

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  70 in total

1.  Structure and function of the visual arrestin oligomer.

Authors:  Susan M Hanson; Ned Van Eps; Derek J Francis; Christian Altenbach; Sergey A Vishnivetskiy; Vadim Y Arshavsky; Candice S Klug; Wayne L Hubbell; Vsevolod V Gurevich
Journal:  EMBO J       Date:  2007-03-01       Impact factor: 11.598

Review 2.  G protein-coupled time travel: evolutionary aspects of GPCR research.

Authors:  Holger Römpler; Claudia Stäubert; Doreen Thor; Angela Schulz; Michael Hofreiter; Torsten Schöneberg
Journal:  Mol Interv       Date:  2007-02

3.  Common structural requirements for heptahelical domain function in class A and class C G protein-coupled receptors.

Authors:  Virginie Binet; Béatrice Duthey; Jennifer Lecaillon; Claire Vol; Julie Quoyer; Gilles Labesse; Jean-Philippe Pin; Laurent Prézeau
Journal:  J Biol Chem       Date:  2007-02-19       Impact factor: 5.157

4.  Structures of the extracellular regions of the group II/III metabotropic glutamate receptors.

Authors:  Takanori Muto; Daisuke Tsuchiya; Kosuke Morikawa; Hisato Jingami
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-26       Impact factor: 11.205

5.  Each rhodopsin molecule binds its own arrestin.

Authors:  Susan M Hanson; Eugenia V Gurevich; Sergey A Vishnivetskiy; Mohamed R Ahmed; Xiufeng Song; Vsevolod V Gurevich
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

6.  Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins.

Authors:  Timothy H Bayburt; Andrew J Leitz; Guifu Xie; Daniel D Oprian; Stephen G Sligar
Journal:  J Biol Chem       Date:  2007-03-29       Impact factor: 5.157

7.  Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit.

Authors:  Oliver P Ernst; Verena Gramse; Michael Kolbe; Klaus Peter Hofmann; Martin Heck
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

8.  A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein.

Authors:  Matthew R Whorton; Michael P Bokoch; Søren G F Rasmussen; Bo Huang; Richard N Zare; Brian Kobilka; Roger K Sunahara
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-23       Impact factor: 11.205

9.  Dimerization of the class A G protein-coupled neurotensin receptor NTS1 alters G protein interaction.

Authors:  Jim F White; Justin Grodnitzky; John M Louis; Loc B Trinh; Joseph Shiloach; Joanne Gutierrez; John K Northup; Reinhard Grisshammer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-09       Impact factor: 11.205

Review 10.  G protein-coupled receptor dimerisation: molecular basis and relevance to function.

Authors:  Graeme Milligan
Journal:  Biochim Biophys Acta       Date:  2006-09-30
View more
  84 in total

Review 1.  Biased signalling and allosteric machines: new vistas and challenges for drug discovery.

Authors:  Terry P Kenakin
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptors.

Authors:  Kuntal Pal; Karsten Melcher; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2012-01-23       Impact factor: 6.150

Review 3.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 4.  Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes.

Authors:  Nicola J Smith; Graeme Milligan
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

5.  Arrestin-rhodopsin binding stoichiometry in isolated rod outer segment membranes depends on the percentage of activated receptors.

Authors:  Martha E Sommer; Klaus Peter Hofmann; Martin Heck
Journal:  J Biol Chem       Date:  2010-12-17       Impact factor: 5.157

Review 6.  GSK-3β activity and hyperdopamine-dependent behaviors.

Authors:  Yan-Chun Li; Wen-Jun Gao
Journal:  Neurosci Biobehav Rev       Date:  2010-08-18       Impact factor: 8.989

7.  Dimeric arrangement of the parathyroid hormone receptor and a structural mechanism for ligand-induced dissociation.

Authors:  Augen A Pioszak; Kaleeckal G Harikumar; Naomi R Parker; Laurence J Miller; H Eric Xu
Journal:  J Biol Chem       Date:  2010-02-19       Impact factor: 5.157

Review 8.  On the fitting of binding data when receptor dimerization is suspected.

Authors:  J Giraldo
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

9.  Instability of a class a G protein-coupled receptor oligomer interface.

Authors:  Jacqueline M Fonseca; Nevin A Lambert
Journal:  Mol Pharmacol       Date:  2009-03-09       Impact factor: 4.436

Review 10.  G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function.

Authors:  Graeme Milligan
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.